Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | HTR2C | P28335 | 2/20 | 0.34 |
| ▸ | HTR2A | P28223 | 1/20 | 0.34 |
| ▸ | HTR2B | P41595 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | HTR1A | P08908 | 1/20 | 0.31 |
| ▸ | HTR1D | P28221 | 1/20 | 0.31 |
| ▸ | HTR7 | P34969 | 1/20 | 0.31 |
| ▸ | HTR5A | P47898 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11926877 | 1.00 | HPGD (0.35) | HPGDHTR2CHTR2AHTR2BL3MBTL1 | |
| SCHEMBL1586522 | 0.90 | MEN1 (0.42) | HPGDL3MBTL1MAPTMEN1KMT2A | |
| SCHEMBL11926875 | 0.90 | MEN1 (0.42) | HPGDL3MBTL1MAPTMEN1KMT2A | |
| SCHEMBL11926878 | 0.84 | L3MBTL1 (0.32) | HPGDL3MBTL1MAPTSLC9A1 | |
| SCHEMBL1586222 | 0.84 | L3MBTL1 (0.32) | HPGDL3MBTL1MAPTSLC9A1 | |
| SCHEMBL11926873 | 0.83 | SLC9A1 (0.50) | HPGDHTR2CHTR2AHTR2BL3MBTL1 | |
| SCHEMBL1586579 | 0.83 | SLC9A1 (0.50) | HPGDHTR2CHTR2AHTR2BL3MBTL1 | |
| SCHEMBL17134248 | 0.82 | HTR2C (0.36) | HTR2CHTR2AHTR2BL3MBTL1SLC9A1 | |
| SCHEMBL17134246 | 0.82 | HTR2C (0.36) | HTR2CHTR2AHTR2BL3MBTL1SLC9A1 | |
| SCHEMBL11926874 | 0.78 | SLC9A1 (0.43) | HPGDHTR2CHTR2AHTR2BL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2488501-B1 | NOVEL MICROBIOCIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2014-04-30 | — | — | EP | disclosed |
| US-8357635-B2 | Microbiocides | SYNGENTA CROP PROTECTION LLC (US) | 2013-01-22 | — | — | US | disclosed |
| EP-2488501-A1 | NOVEL MICROBIOCIDES | Syngenta Participations AG (CH) | 2012-08-22 | — | — | EP | disclosed |
| US-20120202867-A1 | NOVEL MICROBIOCIDES | SYNGENTA CROP PROTECTION LLC (US) | 2012-08-09 | — | — | US | disclosed |
| WO-2011045355-A1 | NOVEL MICROBIOCIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2011-04-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120202867-A1 | NOVEL MICROBIOCIDES | CD14, FPR1, MPO | HPGD 624/4885HTR2C 3036/4885HTR2A 3763/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.